Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status

Abstract Background Although several transcriptome-wide association studies (TWASs) have been performed to identify genes associated with overall breast cancer (BC) risk, only a few TWAS have explored the differences in estrogen receptor-positive (ER+) and estrogen receptor-negative (ER-) breast can...

Full description

Bibliographic Details
Main Authors: Julian C. McClellan, James L. Li, Guimin Gao, Dezheng Huo
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Breast Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13058-024-01809-6
_version_ 1827309885825482752
author Julian C. McClellan
James L. Li
Guimin Gao
Dezheng Huo
author_facet Julian C. McClellan
James L. Li
Guimin Gao
Dezheng Huo
author_sort Julian C. McClellan
collection DOAJ
description Abstract Background Although several transcriptome-wide association studies (TWASs) have been performed to identify genes associated with overall breast cancer (BC) risk, only a few TWAS have explored the differences in estrogen receptor-positive (ER+) and estrogen receptor-negative (ER-) breast cancer. Additionally, these studies were based on gene expression prediction models trained primarily in breast tissue, and they did not account for alternative splicing of genes. Methods In this study, we utilized two approaches to perform multi-tissue TWASs of breast cancer by ER subtype: (1) an expression-based TWAS that combined TWAS signals for each gene across multiple tissues and (2) a splicing-based TWAS that combined TWAS signals of all excised introns for each gene across tissues. To perform this TWAS, we utilized summary statistics for ER + BC from the Breast Cancer Association Consortium (BCAC) and for ER- BC from a meta-analysis of BCAC and the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Results In total, we identified 230 genes in 86 loci that were associated with ER + BC and 66 genes in 29 loci that were associated with ER- BC at a Bonferroni threshold of significance. Of these genes, 2 genes associated with ER + BC at the 1q21.1 locus were located at least 1 Mb from published GWAS hits. For several well-studied tumor suppressor genes such as TP53 and CHEK2 which have historically been thought to impact BC risk through rare, penetrant mutations, we discovered that common variants, which modulate gene expression, may additionally contribute to ER + or ER- etiology. Conclusions Our study comprehensively examined how differences in common variation contribute to molecular differences between ER + and ER- BC and introduces a novel, splicing-based framework that can be used in future TWAS studies.
first_indexed 2024-04-24T19:50:14Z
format Article
id doaj.art-1149dce07d1b47f78b1ae6632b5b62de
institution Directory Open Access Journal
issn 1465-542X
language English
last_indexed 2024-04-24T19:50:14Z
publishDate 2024-03-01
publisher BMC
record_format Article
series Breast Cancer Research
spelling doaj.art-1149dce07d1b47f78b1ae6632b5b62de2024-03-24T12:37:58ZengBMCBreast Cancer Research1465-542X2024-03-0126111510.1186/s13058-024-01809-6Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor statusJulian C. McClellan0James L. Li1Guimin Gao2Dezheng Huo3Department of Public Health Sciences, University of ChicagoDepartment of Public Health Sciences, University of ChicagoDepartment of Public Health Sciences, University of ChicagoDepartment of Public Health Sciences, University of ChicagoAbstract Background Although several transcriptome-wide association studies (TWASs) have been performed to identify genes associated with overall breast cancer (BC) risk, only a few TWAS have explored the differences in estrogen receptor-positive (ER+) and estrogen receptor-negative (ER-) breast cancer. Additionally, these studies were based on gene expression prediction models trained primarily in breast tissue, and they did not account for alternative splicing of genes. Methods In this study, we utilized two approaches to perform multi-tissue TWASs of breast cancer by ER subtype: (1) an expression-based TWAS that combined TWAS signals for each gene across multiple tissues and (2) a splicing-based TWAS that combined TWAS signals of all excised introns for each gene across tissues. To perform this TWAS, we utilized summary statistics for ER + BC from the Breast Cancer Association Consortium (BCAC) and for ER- BC from a meta-analysis of BCAC and the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Results In total, we identified 230 genes in 86 loci that were associated with ER + BC and 66 genes in 29 loci that were associated with ER- BC at a Bonferroni threshold of significance. Of these genes, 2 genes associated with ER + BC at the 1q21.1 locus were located at least 1 Mb from published GWAS hits. For several well-studied tumor suppressor genes such as TP53 and CHEK2 which have historically been thought to impact BC risk through rare, penetrant mutations, we discovered that common variants, which modulate gene expression, may additionally contribute to ER + or ER- etiology. Conclusions Our study comprehensively examined how differences in common variation contribute to molecular differences between ER + and ER- BC and introduces a novel, splicing-based framework that can be used in future TWAS studies.https://doi.org/10.1186/s13058-024-01809-6BreastCancerTWASEstrogenReceptorSplicing
spellingShingle Julian C. McClellan
James L. Li
Guimin Gao
Dezheng Huo
Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status
Breast Cancer Research
Breast
Cancer
TWAS
Estrogen
Receptor
Splicing
title Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status
title_full Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status
title_fullStr Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status
title_full_unstemmed Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status
title_short Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status
title_sort expression and splicing based multi tissue transcriptome wide association studies identified multiple genes for breast cancer by estrogen receptor status
topic Breast
Cancer
TWAS
Estrogen
Receptor
Splicing
url https://doi.org/10.1186/s13058-024-01809-6
work_keys_str_mv AT juliancmcclellan expressionandsplicingbasedmultitissuetranscriptomewideassociationstudiesidentifiedmultiplegenesforbreastcancerbyestrogenreceptorstatus
AT jameslli expressionandsplicingbasedmultitissuetranscriptomewideassociationstudiesidentifiedmultiplegenesforbreastcancerbyestrogenreceptorstatus
AT guimingao expressionandsplicingbasedmultitissuetranscriptomewideassociationstudiesidentifiedmultiplegenesforbreastcancerbyestrogenreceptorstatus
AT dezhenghuo expressionandsplicingbasedmultitissuetranscriptomewideassociationstudiesidentifiedmultiplegenesforbreastcancerbyestrogenreceptorstatus